Literature DB >> 14595489

[Myelopathy: clinical considerations and etiological aspects].

José Correia de Farias Brito1, Paulo Virgolino da Nóbrega.   

Abstract

We studied 97 inpatients with myelopathy at the University Hospital Lauro Wanderley from 1985 to 2002. Ages ranged from 10 to 78 years and average age was 39.8 years. All patients were examined by neurologist. Cerebrospinal fluid (CSF) was analysed in 44 (45.3%) cases and immunofluorescence reactions and/or ELISA in CSF were made in 32 (32.9%) cases. Radiologic investigation of the vertebral spine and spinal cord of the 32 (32.9%) cases consisted of 8 radiographies, 10 computed tomography and 14 magnetic resonance image. In 41 (42.2%) cases the lesions were situated in the lower dorsal and lumbar level and complete transverse lesion were registred in 61 (62.8%) cases. There was predominance of transverse myelitis (43.2%) and spinal cord compression (15.46%). Spinal cord schistosomiasis was the form more often of the transverse myelitis (13.4%).

Entities:  

Mesh:

Year:  2003        PMID: 14595489     DOI: 10.1590/s0004-282x2003000500021

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

1.  Acute myelitis associated with HCV infection.

Authors:  Kentaro Suzuki; Masaki Takao; Yasuo Katayama; Ban Mihara
Journal:  BMJ Case Rep       Date:  2013-06-13

2.  Schistosomal myeloradiculopathy due to Schistosoma mansoni: Report on 17 cases from an endemic area.

Authors:  Hatem I Badr; Ashraf A Shaker; Mohamed A Mansour; Mohamed A Kasem; Ahmad A Zaher; Hassan H Salama; Mohamed I Safwat
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

3.  Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy.

Authors:  Felipe von Glehn; Sven Jarius; Augusto C Penalva de Oliveira; Carlos Otávio Brandão; Alessandro S Farias; Alfredo Damasceno; Jorge Casseb; Adriel S Moraes; Ana Leda F Longhini; Klaus-Peter Wandinger; Benito P Damasceno; Brigitte Wildemann; Leonilda M B Santos
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.